Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Becton, Dickinson Says Rapid Antigen, PCR Tests Capable of Detecting Omicron Variant

11/30/2021 | 07:28am EST


ę MT Newswires 2021
All news about BECTON, DICKINSON AND COMPANY
02:02pBD Innovation Profiled in Cover Story of 'Science' Demonstrates Landmark Advancement in..
PR
01/12BD Named One of America's Most Just Companies in Annual JUST 100 Ranking
AQ
01/11BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship P..
PR
01/11Becton, Dickinson and Company and Pfizer Inc Collaborates to Improve Global Hospital An..
CI
01/11US to Require Insurers to Pay for At-Home COVID-19 Tests
MT
01/10BD Introduces Smart Connected Robotics to Automate Microbial Identification
AQ
01/07Becton, Dickinson, and Co. Gets US FDA 510(k) Clearance for Bacterial Identification Te..
MT
01/07BD Introduces Smart Connected Robotics to Automate Microbial Identification
PR
01/07Becton, Dickinson and Company Receives 510(K) Clearance from the U.S. Food and Drug Adm..
CI
01/06BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
PR
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 19 459 M - -
Net income 2022 2 337 M - -
Net Debt 2022 12 756 M - -
P/E ratio 2022 33,5x
Yield 2022 1,43%
Capitalization 75 243 M 75 243 M -
EV / Sales 2022 4,52x
EV / Sales 2023 4,22x
Nbr of Employees 75 000
Free-Float 77,4%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 263,97 $
Average target price 272,62 $
Spread / Average Target 3,28%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY4.93%75 214
ABBOTT LABORATORIES-10.44%216 172
MEDTRONIC PLC4.17%144 890
HOYA CORPORATION-12.71%48 228
BAXTER INTERNATIONAL INC.-0.28%42 859
DEXCOM, INC.-18.94%42 183